This announcement is a separate document:
昭衍新药：昭衍新药2024年第三季度报告
Zhaoyan Pharmaceutical: Zhaoyan New Pharmaceutical Report for the Third Quarter of 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
02:46
5年规模增长超10倍 跨境电商成外贸发展新引擎
02:40
Intercontinental Exchange: As of the week ending January 7, speculators' net long positions in Brent Crude Oil increased by 39,944 contracts to 226,859 contracts. Speculators' net long positions in RBOB Gasoline increased by 9,504 contracts to 32,377 contracts.
ICE-1.65%
02:33
The Lebanese Ministry of Health: The Israeli airstrike on southern Lebanon resulted in five deaths.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.